Metastatic Colorectal Cancers Completed Phase Trials for Cetuximab (DB00002)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01382407Does Acne Rash During Adolescence Predict Skin Reaction to Cetuximab
NCT01280643Combination Chemotherapy and Cetuximab or Bevacizumab in Treating Patients With Metastatic Colorectal CancerTreatment
NCT02994888PROSPECT-C: A Study of Biomarkers of Response or Resistance to Anti-EGFR Therapies in Metastatic Colorectal Cancer